Matthias Niedrig

Author PubWeight™ 89.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences. J Virol 2010 3.01
2 S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol 2004 1.80
3 Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol 2004 1.74
4 Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect 2002 1.64
5 A clear and present danger: tick-borne diseases in Europe. Expert Rev Anti Infect Ther 2010 1.61
6 Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods 2003 1.54
7 Coronavirus antibodies in African bat species. Emerg Infect Dis 2007 1.54
8 Detection of yellow fever 17D genome in urine. J Clin Microbiol 2010 1.52
9 Detection of West Nile virus lineages 1 and 2 by real-time PCR. J Virol Methods 2007 1.49
10 Alkhumra, not Alkhurma, is the correct name of the new hemorrhagic fever flavivirus identified in Saudi Arabia. Intervirology 2012 1.48
11 Multicentre evaluation of central nervous system infections due to Flavi and Phleboviruses in Turkey. J Infect 2012 1.43
12 Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects. Acta Trop 2004 1.39
13 2nd International external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl Trop Dis 2010 1.34
14 Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol 2005 1.33
15 Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol 2013 1.27
16 Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol 2010 1.27
17 Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods 2008 1.26
18 Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol 2012 1.23
19 Quality control assessment for the serological diagnosis of dengue virus infections. J Clin Virol 2004 1.14
20 Serologic evidence of West Nile virus infections in wild birds captured in Germany. Am J Trop Med Hyg 2007 1.12
21 Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol 2015 1.11
22 External quality control assessment in PCR diagnostics of dengue virus infections. J Clin Virol 2004 1.09
23 Factors affecting patterns of tick parasitism on forest rodents in tick-borne encephalitis risk areas, Germany. Parasitol Res 2010 1.09
24 Alkhumra (Alkhurma) virus outbreak in Najran, Saudi Arabia: epidemiological, clinical, and laboratory characteristics. J Infect 2010 1.08
25 SARS molecular detection external quality assurance. Emerg Infect Dis 2004 1.08
26 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005. Vaccine 2006 1.05
27 Characterisation of human tick-borne encephalitis virus from Sweden. J Med Virol 2003 1.05
28 Tick burden on European roe deer (Capreolus capreolus). Exp Appl Acarol 2010 1.05
29 SARS transmission and commercial aircraft. Emerg Infect Dis 2004 1.04
30 Coordinated implementation of chikungunya virus reverse transcription-PCR. Emerg Infect Dis 2009 1.03
31 Type 1 diabetes in Swedish bank voles (Clethrionomys glareolus): signs of disease in both colonized and wild cyclic populations at peak density. Ann N Y Acad Sci 2003 1.00
32 Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill 2015 0.97
33 West Nile virus monitoring of migratory and resident birds in Germany. Vector Borne Zoonotic Dis 2010 0.97
34 Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clin Infect Dis 2009 0.97
35 Dengue antibody prevalence in German travelers. Emerg Infect Dis 2005 0.96
36 First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis 2012 0.96
37 Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis 2008 0.96
38 High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae. J Biotechnol 2004 0.96
39 Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis 2004 0.95
40 A new quantitative real-time reverse transcriptase PCR assay and melting curve analysis for detection and genotyping of Ljungan virus strains. J Virol Methods 2006 0.95
41 Rickettsia aeschlimannii in Hyalomma marginatum ticks, Germany. Emerg Infect Dis 2011 0.94
42 Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2012 0.94
43 Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop. BMC Infect Dis 2014 0.93
44 Molecular surveillance of circulating dengue genotypes through European travelers. J Travel Med 2011 0.92
45 Evaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccination. PLoS Negl Trop Dis 2010 0.92
46 Safety of 17D derived yellow fever vaccines. Expert Opin Drug Saf 2009 0.92
47 Rodents as sentinels for the prevalence of tick-borne encephalitis virus. Vector Borne Zoonotic Dis 2011 0.92
48 Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses 2013 0.91
49 Performance of various commercial assays for the detection of Toscana virus antibodies. Vector Borne Zoonotic Dis 2011 0.90
50 Determinants of tick-borne encephalitis in counties of southern Germany, 2001-2008. Int J Health Geogr 2010 0.89
51 Second external quality assessment of the molecular diagnostic of West Nile virus: are there improvements towards the detection of WNV? J Clin Virol 2011 0.89
52 Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses. Virol J 2013 0.88
53 Quality control assessment for the PCR diagnosis of tick-borne encephalitis virus infections. J Clin Virol 2006 0.88
54 Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA. J Clin Virol 2004 0.88
55 International external quality assessment of molecular detection of Rift Valley fever virus. PLoS Negl Trop Dis 2013 0.88
56 Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity. Virus Genes 2005 0.88
57 Safety profile of the yellow fever vaccine Stamaril®: a 17-year review. Expert Rev Vaccines 2013 0.88
58 Quality control measures for the serological diagnosis of hantavirus infections. J Clin Virol 2003 0.87
59 First international external quality assessment study on molecular and serological methods for yellow fever diagnosis. PLoS One 2012 0.87
60 Chikungunya fever in Israeli travelers returning from northwestern India. J Travel Med 2008 0.87
61 Biological and phylogenetic characteristics of yellow fever virus lineages from West Africa. J Virol 2012 0.86
62 Second external quality assurance study for the serological diagnosis of hantaviruses in Europe. PLoS Negl Trop Dis 2012 0.86
63 Diagnosis of tick-borne encephalitis by a mu-capture immunoglobulin M-enzyme immunoassay based on secreted recombinant antigen produced in insect cells. J Clin Microbiol 2003 0.86
64 The early cellular signatures of protective immunity induced by live viral vaccination. Eur J Immunol 2012 0.86
65 Detection and differentiation of tick-borne encephalitis virus subtypes by a reverse transcription quantitative real-time PCR and pyrosequencing. J Virol Methods 2010 0.86
66 West Nile virus monitoring in migrating and resident water birds in Iran: are common coots the main reservoirs of the virus in wetlands? Vector Borne Zoonotic Dis 2011 0.85
67 The phylogeny of yellow fever virus 17D vaccines. Vaccine 2011 0.85
68 Tickborne encephalitis virus antibodies in wild cervids in Belgium. Vet Rec 2012 0.85
69 Medical importance of Sindbis virus in south-west Germany. J Clin Virol 2011 0.85
70 [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey]. Mikrobiyol Bul 2010 0.84
71 Human coronavirus NL63 open reading frame 3 encodes a virion-incorporated N-glycosylated membrane protein. Virol J 2010 0.84
72 Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosis of SARS. J Med Virol 2005 0.83
73 Clinical features and pitfalls in the laboratory diagnosis of dengue in travellers. BMC Infect Dis 2006 0.82
74 Second international diagnostic accuracy study for the serological detection of West Nile virus infection. PLoS Negl Trop Dis 2013 0.82
75 Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe. PLoS One 2013 0.82
76 rapidSTRIPE H1N1 test for detection of the pandemic swine origin influenza A (H1N1) virus. J Clin Microbiol 2011 0.82
77 SARS coronavirus detection. Emerg Infect Dis 2004 0.81
78 Human granulocytic anaplasmosis acquired in Scotland, 2013. Emerg Infect Dis 2014 0.80
79 Tick-borne encephalitis virus triggers inositol-requiring enzyme 1 (IRE1) and transcription factor 6 (ATF6) pathways of unfolded protein response. Virus Res 2013 0.80
80 Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses. PLoS Negl Trop Dis 2013 0.80
81 RNA interference inhibits replication of tick-borne encephalitis virus in vitro. Antiviral Res 2011 0.79
82 International laboratory network for yellow fever vaccine-associated adverse events. Vaccine 2008 0.78
83 Evaluation of different serological diagnostic methods for tick-borne encephalitis virus: enzyme-linked immunosorbent, immunofluorescence, and neutralization assay. Vector Borne Zoonotic Dis 2013 0.78
84 [Flavivirus seroepidemiology in blood donors in Mersin province, Turkey]. Mikrobiyol Bul 2014 0.78
85 Cross-sectional survey on hantavirus seroprevalence in Canton St. Gallen, Switzerland. Swiss Med Wkly 2007 0.78
86 Differentiation of medically important Euro-Asian tick species Ixodes ricinus, Ixodes persulcatus, Ixodes hexagonus, and Dermacentor reticulatus by polymerase chain reaction. Vector Borne Zoonotic Dis 2010 0.77
87 High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool. J Heart Lung Transplant 2005 0.75
88 Frequent detection of viral nucleic acids in heart valve tissue. J Clin Microbiol 2004 0.75
89 Statistical approach for optimization of external quality assurance (EQA) studies of molecular and serological viral diagnostics. Clin Chem Lab Med 2016 0.75
90 Clinical and laboratory features of dengue virus-infected travellers previously vaccinated against yellow fever. Scand J Infect Dis 2003 0.75
91 Development and characterization of murine monoclonal antibodies to first and second Ljungan virus genotypes. J Virol Methods 2012 0.75
92 State-of-the-art serological techniques for detection of antibodies against tick-borne encephalitis virus. Int J Med Microbiol 2004 0.75
93 Clinical implications of and lessons learnt from external assessment of Mers-CoV diagnostics. Expert Rev Mol Diagn 2015 0.75